GENE ONLINE|News &
Opinion
Blog

2019-12-31| M&ASpecial

GeneOnline’s Top Mergers and Acquisitions of 2019

by Rajaneesh K. Gopinath
Share To
2019 was a year replete with major pharma, biotech, and digital healthcare deals. Here we highlight some of the major mergers and acquisitions of the year.

The year 2019 began with the big news of Bristol-Myers Squibb (BMS) agreeing to acquire Celgene Corporation for a value of about US$ 74 billion.According to data compiled by Refinitiv,

GO Prime with only $1.49 now

LATEST
BIODND – An AI-Powered Database That Breaks New Ground in Life Science Business Development
2023-11-29
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
Scroll to Top